 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Guardion Health Sciences GAAP EPS of $0.12, revenue of $12.25M...

Guardion Health Sciences GAAP EPS of $0.12, revenue of $12.25M

Viactiv Product Line Generated Net Revenues of Approximately $11.9 Million for the Year Ended December 31, 2023, an Increase of Approximately 12% as Compared to the Year Ended December 31, 2022...

Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023

Argos Therapeutics (OTCMKTS:ARGSQ  Get Free Report) and Guardion Health Sciences (NASDAQ:GHSI  Get Free Report) are both small-cap medical companies, but which is the superior...

Argos Therapeutics (OTCMKTS:ARGSQ) vs. Guardion Health Sciences (NASDAQ:GHSI) Head-To-Head Analysis

Propanc Biopharma (OTCMKTS:PPCB  Get Free Report) and Guardion Health Sciences (NASDAQ:GHSI  Get Free Report) are both small-cap medical companies, but which is the better stock? We...

Contrasting Propanc Biopharma (OTCMKTS:PPCB) and Guardion Health Sciences (NASDAQ:GHSI)

Guardion Health Sciences (NASDAQ:GHSI  Get Free Report) and Amarin (NASDAQ:AMRN  Get Free Report) are both small-cap medical companies, but which is the better business? We will...

Guardion Health Sciences (NASDAQ:GHSI) vs. Amarin (NASDAQ:AMRN) Financial Review

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Maxim gets more bearish on Guardion Health Sciences, downgrades shares

Guardion Health Sciences to sell Viactiv brand and business to Doctor's Best

HOUSTON, TEXAS, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) ( Guardion or the Company ) announced today that it has signed an equity purchase agreement to sell...

Guardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv  Brand and Business to Doctor's Best Inc.

Guardion Health Sciences, Inc. engages in the development and distribution of clinically supported dietary supplements and medical foods. The firm also offers science-based products and devices designed to support healthcare professionals, providers, patients, and consumers. The company was founded by Michael Favish in December 2009 and is headquartered in Houston, TX.

Volume (M)	2,250.00
52-Wk High	$10.75
52-Wk Low	$5.01

GHSI Guardion Health Sciences Inc

About

Feed

News

Fundamentals